Why Choose Korea for Medical Treatment?
Korea ranks #2 globally for healthcare quality, welcomed 1.17 million international patients in 2024, and offers savings of 40-90% vs the US.
Korea's Healthcare Rankings
When multiple independent ranking systems consistently place Korea near the top, the signal is clear.
| Ranking System | Korea's Position |
|---|---|
| CEOWORLD Healthcare Index | #2 globally (behind Taiwan) |
| Numbeo Health Care Index | Top 5 globally |
| Newsweek World's Best Hospitals | 18 Korean hospitals listed (#3 by count) |
| Newsweek Best Specialized Hospitals | Severance Orthopedics #10 globally |
| Lancet Healthcare Access & Quality | Top 10 globally |
1.17 Million Patients Can't All Be Wrong
In 2024, Korea welcomed a record 1,170,467 international patients - a 93.2% increase over 2023 and more than triple pre-COVID levels.
From 320,284 patients in 2019 to 1,170,467 in 2024 - more than triple pre-COVID levels. The 2025 government target is 1.3-1.4 million.
Patients from 190+ countries. Top sources: Japan, China, the US, Thailand, Taiwan, and Russia. American patients are a fast-growing segment.
International medical tourism generated ₩3.66 trillion (~$2.47 billion) in medical revenue in 2024. Total economic impact including companions: ~$5.2 billion.
Seoul captured 85% of all medical tourists (999,642 patients), making it one of the world's leading medical tourism cities.
JCI Accreditation: What It Means
JCI is the gold standard for hospital quality certification worldwide - the international arm of The Joint Commission, which accredits over 80% of US hospitals.
JCI evaluates patient safety, medication management, infection prevention, surgical safety, emergency preparedness, staff qualifications, and facility safety.
An outside organization - not the hospital itself - verifies that safety and quality standards meet international benchmarks. Re-certification required every 3 years.
Being JCI-accredited puts a Korean hospital in a genuinely elite category. Korea has 30+ JCI-accredited hospitals - large, university-affiliated medical centers.
Severance: first JCI hospital in Korea (2007). KU Anam: 5 consecutive accreditations. Seoul St. Mary's: JCI accredited. These are verifiable standards, not marketing claims.
Government Support & Patient Protection
Korea's medical tourism industry is backed by billions in government investment, strict regulation, and established patient protections.
KHIDI Oversight
Korea Health Industry Development Institute certifies hospitals, operates support centers, publishes quality reports, and manages the official Medical Korea platform.
Mandatory Malpractice Insurance
Required by law since 2016 for every Korean medical institution treating international patients. Financial protection if something goes wrong.
MOHW Registration
Hospitals must register with the Ministry of Health and Welfare to treat international patients - meeting standards for facilities, staffing, and safety.
Patient Complaint Hotlines
Medical Tourism Hotline: 1577-7129. Emergency: 1339 (English 24/7). Seoul Medical Tourism Center available on-site at major hospitals.
Licensed Facilitators
Medical tourism agencies must be licensed by the government. InKoreaNow holds License A-2025-01-02-5886 - regulated, monitored, and accountable.
VAT Refund
International patients receive a 10% VAT refund on cosmetic procedures at registered institutions. InKoreaNow assists with the refund process.
The Cost Reality
Lower prices do NOT mean lower quality. The gap exists because of lower overhead, government investment, competition, and no insurance pricing games.
| Category | Typical Savings vs US |
|---|---|
| Health Checkups | 70-80% |
| Skincare & Dermatology | 55-90% |
| Dental & Orthodontics | 40-75% |
| Plastic Surgery | 35-75% |
| Fertility & IVF | 50-70% |
| Cancer Treatment | 60-90% |
| Cardiac Surgery | 55-90% |
| Orthopedic Surgery | 38-80% |
Technology & Innovation
Among the highest Da Vinci robotic surgery volumes globally. KU Anam is #1 in Asia for robotic bladder cancer surgery. Medical robotics market projected to reach $2.4B by 2035.
Korean AI company Lunit is deployed in 200+ US hospitals for cancer screening. AI-assisted analysis is part of the standard health checkup workflow, not an expensive add-on.
Three proton centers plus Asia's first carbon-ion facility at Yonsei. Only ~15 carbon-ion facilities exist worldwide. $15,000-$30,000 in Korea vs $150,000-$200,000 in the US.
Korea's Regenerative Medicine Law (2025) makes cutting-edge therapies accessible. Seoul St. Mary's: 10,000+ stem cell transplants -#1 Asia, #5 globally.